Related Pages for FORTIS
- Option Chain
- Straddle OC
- Max Pain
- Put Call Ratio
- Option Analytics
- Call OI vs Put OI
- Strike Flow
- Call OI Chg vs Put OI Chg
- Call Vol vs Put Vol
- Buildup & Unwinding
- Vega Divergence
- Multi Strike OI
- Multi Straddle Analysis
- Price vs OI
- Time Series Table
- Time Series Multi Chart
- Volatility Skew
- Premium Decay
- IV - HV
- IV Intraday
- Future Chain
- Future Intraday Analysis
- Technical
- Financials
- Chart
- About
No results found.
FORTIS
Related News - FORTIS
Fortis Healthcare: Guidance - Management maintains its consolidated EBITDA margin guidance for FY27, expecting to achieve 25% EBITDA margin by FY28, inclusive of ESOP costs, which will be offset by operational improvements.- Concall Update
10 Aug 2026 09:05 AM
Fortis Healthcare: Guidance - Management maintains its consolidated EBITDA margin guidance for FY27, expecting to achieve 25% EBITDA margin by FY28, inclusive of ESOP costs, which will be offset by operational improvements.- Concall Update
Fortis Healthcare: Guidance - For the Diagnostic Business, management expects revenue growth of 12-13% and EBITDA margins of 24-25% for the remaining quarters of FY27, driven by continued momentum and an improved B2C mix.- Concall Update
10 Aug 2026 09:05 AM
Fortis Healthcare: Guidance - For the Diagnostic Business, management expects revenue growth of 12-13% and EBITDA margins of 24-25% for the remaining quarters of FY27, driven by continued momentum and an improved B2C mix.- Concall Update
Fortis Healthcare: Guidance - The company plans to operationalize an additional 400 beds in the remaining three quarters of FY27, including 200 beds from the FMRI facility, and anticipates CapEx consuming approximately 50% of EBITDA for brownfield expansion and technical upgrades.- Concall Update
10 Aug 2026 09:05 AM
Fortis Healthcare: Guidance - The company plans to operationalize an additional 400 beds in the remaining three quarters of FY27, including 200 beds from the FMRI facility, and anticipates CapEx consuming approximately 50% of EBITDA for brownfield expansion and technical upgrades.- Concall Update
Fortis Healthcare: Guidance - Key levers for margin improvement include new units (Manesar, Noida, FMRI) transitioning to positive EBITDA contribution, improved collection from government and TPAs, and increased occupancy in existing hospitals like BG Road and Mulund.- Concall Update
10 Aug 2026 09:05 AM
Fortis Healthcare: Guidance - Key levers for margin improvement include new units (Manesar, Noida, FMRI) transitioning to positive EBITDA contribution, improved collection from government and TPAs, and increased occupancy in existing hospitals like BG Road and Mulund.- Concall Update
Fortis Healthcare: Guidance - The company is actively evaluating inorganic growth opportunities, focusing on existing clusters, and has approved a INR252 crore CapEx for a Proton facility at its Gurgaon hospital.- Concall Update
10 Aug 2026 09:05 AM
Fortis Healthcare: Guidance - The company is actively evaluating inorganic growth opportunities, focusing on existing clusters, and has approved a INR252 crore CapEx for a Proton facility at its Gurgaon hospital.- Concall Update
Fortis Health: Expects EBITDA Margin From Diagnostic Operations To Stay Between 24-25% Over The Next 5 Years - Concall Update
07 Aug 2026 12:35 PM
Fortis Health: Expects EBITDA Margin From Diagnostic Operations To Stay Between 24-25% Over The Next 5 Years - Concall Update
Fortis Healthcare: Plans Three New Cancer Hospitals In Faridabad, Amritsar, And Jaipur - Concall Update
07 Aug 2026 11:49 AM
Fortis Healthcare: Plans Three New Cancer Hospitals In Faridabad, Amritsar, And Jaipur - Concall Update
Fortis Healthcare: Plans To Add 400 Beds In Hospitals Over The Next Three Quarters In FY27. - Concall Update
07 Aug 2026 11:37 AM
Fortis Healthcare: Plans To Add 400 Beds In Hospitals Over The Next Three Quarters In FY27. - Concall Update
Fortis Healthcare: Aims To Maintain 25% EBITDA Margin Goal For FY27 - Concall Update.
07 Aug 2026 11:38 AM
Fortis Healthcare: Aims To Maintain 25% EBITDA Margin Goal For FY27 - Concall Update.
Fortis: Nomura on Fortis Maintains Neutral with Target Price of ₹990 as 1QFY27 sales beat estimates by 3%, but EBITDA and margin missed by 3% and 130bps, respectively, partly due to a ₹307mn ESOP charge; excluding the ₹95mn exceptional gain from impairment reversal, PAT was in line.
07 Aug 2026 08:58 AM
Fortis: Nomura on Fortis Maintains Neutral with Target Price of ₹990 as 1QFY27 sales beat estimates by 3%, but EBITDA and margin missed by 3% and 130bps, respectively, partly due to a ₹307mn ESOP charge; excluding the ₹95mn exceptional gain from impairment reversal, PAT was in line.
FORTIS HEALTHCARE: Q1 CONS NET PROFIT 2.73B RUPEES VS 2.67B (YOY)
06 Aug 2026 07:18 PM
FORTIS HEALTHCARE: Q1 CONS NET PROFIT 2.73B RUPEES VS 2.67B (YOY)
FORTIS HEALTHCARE: Q1 REVENUE 25.45B RUPEES VS 21.67B (YOY)
06 Aug 2026 07:19 PM
FORTIS HEALTHCARE: Q1 REVENUE 25.45B RUPEES VS 21.67B (YOY)
FORTIS HEALTHCARE: Q1 EBITDA 5.41B RUPEES VS 4.91B (YOY) || Q1 EBITDA MARGIN 21.28% VS 22.65% (YOY)
06 Aug 2026 07:19 PM
FORTIS HEALTHCARE: Q1 EBITDA 5.41B RUPEES VS 4.91B (YOY) || Q1 EBITDA MARGIN 21.28% VS 22.65% (YOY)
Fortis Healthcare: Announces Q1 Earnings Call Scheduled For August 7 At 11 AM
30 Jul 2026 09:27 PM
Fortis Healthcare: Announces Q1 Earnings Call Scheduled For August 7 At 11 AM
Fortis Healthcare: Agilus Diagnostics Appoints Vijender Singh As Managing Director & Chief Executive Officer; Previously Mr. Singh Held Leadership Positions As Group CEO Of Metropolis Healthcare.
20 Jul 2026 03:20 PM
Fortis Healthcare: Agilus Diagnostics Appoints Vijender Singh As Managing Director & Chief Executive Officer; Previously Mr. Singh Held Leadership Positions As Group CEO Of Metropolis Healthcare.
Fortis Healthcare: Signs Agreement With Dion Group To Run A New 300-Bed Multi-Specialty Hospital In Cuttack, Entering Odisha Market.
03 Jul 2026 05:44 PM
Fortis Healthcare: Signs Agreement With Dion Group To Run A New 300-Bed Multi-Specialty Hospital In Cuttack, Entering Odisha Market.
Fortis Healthcare: Sees Tax Demand Cut From ₹117.04 Crores To ₹61.48 Crores For AY 2024-25.
17 Jun 2026 12:06 PM
Fortis Healthcare: Sees Tax Demand Cut From ₹117.04 Crores To ₹61.48 Crores For AY 2024-25.
Fortis Health: Plans To Increase Capacity By Adding 2,000 Beds Over The Next Three Years, With 500 Beds Expected To Be Available In 2027.
25 May 2026 11:19 AM
Fortis Health: Plans To Increase Capacity By Adding 2,000 Beds Over The Next Three Years, With 500 Beds Expected To Be Available In 2027.
FORTIS HEALTHCARE: Q4 CONS NET PROFIT 2.7B RUPEES VS 1.9B (YOY) || Q4 REVENUE 23.6B RUPEES VS 20B (YOY)
22 May 2026 08:01 PM
FORTIS HEALTHCARE: Q4 CONS NET PROFIT 2.7B RUPEES VS 1.9B (YOY) || Q4 REVENUE 23.6B RUPEES VS 20B (YOY)
FORTIS HEALTHCARE: Q4 EBITDA 5.3B RUPEES VS 4.4B (YOY) || Q4 EBITDA MARGIN 22.51% VS 21.93% (YOY)
22 May 2026 08:02 PM
FORTIS HEALTHCARE: Q4 EBITDA 5.3B RUPEES VS 4.4B (YOY) || Q4 EBITDA MARGIN 22.51% VS 21.93% (YOY)
